Join
Live feed
·
INSIDERFilingvia Quantisnow
Humacyte Inc. logo

Chief Commercial Officer Scheessele William John bought $9,999 worth of shares (6,493 units at $1.54), increasing direct ownership by 42% to 22,018 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
HUMA· Humacyte Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HUMA (Humacyte Inc.) and more on Quantisnow.